Orthofix Medical Inc (OFIX)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $292.25M
Last updated: Nov 17, 2026 at 11:05 AM ET
Orthofix Medical Inc (OFIX) Stock Forecast
Analysts expect Orthofix Medical (OFIX) to earn $0.43 per share in the fiscal year ending Dec 31, 2026, on revenue of $827.09M. Of 4 analysts, 3 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 75% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 25.0% |
| Buy | 2 | 50.0% |
| Hold | 1 | 25.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 4
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus falls 58.1% and revenue estimates fall 0.9%.
- Fiscal year ending Dec 31, 2026
- $0.43
- EPS consensus, revenue $827.09M
- Fiscal year ending Dec 31, 2027
- $0.18
- EPS consensus, revenue $819.96M
- Next report
- Feb 22, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.43 | $0.43 to $0.43 | 1 | $827.09M | $826.90M to $827.40M | 4 |
| Dec 31, 2027 | $0.18 | $0.18 to $0.18 | 1 | $819.96M | $812.56M to $822.99M | 4 |
Quarterly Estimates
The EPS consensus falls from -$0.07 for the quarter ending Dec 31, 2026 to -$0.20 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.07 | -$0.12 to -$0.02 | 4 | $216.03M | $207.17M to $222.92M | 6 |
| Mar 31, 2027 | -$0.20 | -$0.20 to -$0.20 | 1 | $190.84M | $188.14M to $193.38M | 3 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 3 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
| Quarter ending Mar 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 4.9% from $0.41.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.43 | $0.41 | $0.41 | $0.41 | $0.41 | +4.9% |
| Fiscal year ending Dec 31, 2027 | $0.18 | $0.37 | $0.37 | $0.37 | $0.37 | -51.4% |
| Quarter ending Mar 31, 2027 | -$0.20 | -$0.20 | -$0.20 | -$0.20 | -$0.25 | N/A |
Frequently Asked Questions About OFIX
What is the OFIX stock forecast?
Consensus analyst estimates put Orthofix Medical's EPS at $0.43 for the fiscal year ending Dec 31, 2026, on revenue of $827.09M. The consensus rating from 4 analysts is Buy.
How do analysts rate OFIX stock?
Of 4 analysts covering Orthofix Medical, 1 rates it Strong Buy, 2 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from OFIX next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.43, with estimates from $0.43 to $0.43 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.18, with estimates from $0.18 to $0.18 from 1 analyst.
What revenue do analysts expect from Orthofix Medical next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $827.09M, with estimates from $826.90M to $827.40M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $819.96M, with estimates from $812.56M to $822.99M.
How many analysts cover OFIX?
4 analysts rate Orthofix Medical stock, and 1 analyst estimates its EPS for the fiscal year ending Dec 31, 2026.
OFIX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors